Crossmark

An engineered E. coli strain sustains intratumoral nitric oxide production to boost effectiveness of tumor immunotherapy

Published Online: 2026-03-18

Funding

Funding for this research was provided by:

National Natural Science Foundation of China (32271443)

the Research Project of Peking University Third Hospital in State Key Laboratory of Vascular Homeostasis and Remodeling (Peking University)
License Information

Text and Data Mining valid from 2026-03-18

Version of Record valid from 2026-03-18
More Information

Article History

First Online: 18 March 2026

Document is current